Active Funding Opportunity Announcements (FOAs) for All NICHD
NICHD issues and participates in various FOAs to support research activities and training.
Investigator-Initiated (Unsolicited) Projects
To submit unsolicited or investigator-initiated applications, use the appropriate NIH Parent Announcement.
Active FOAs for NICHD
Please note: The following FOAs are sorted by date, from most recent to oldest. Select a table heading to change how to sort and display the FOAs.
| Announcement Number | Submissions Date(s) | Expiration Date | Activity Code(s) | Title |
|---|---|---|---|---|
| PAR-20-161 | September 14, 2020, March 17, 2021, March 17, 2022, March 17, 2023 | March 18, 2023 | X01 | Catalyzing Innovation in Pediatric Pharmacology Clinical Trial Design and Resource Access (X01 Clinical Trial Not Allowed) |
| RFA-HD-21-009 | August 14, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
August 15, 2020 | P50 | Intellectual and Developmental Disabilities Reserch Centers [IDDRC] FY 2021 (P50 Clinical Trial Optional) |
| RFA-NS-20-029 | July 14, 2020 and June 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | June 16, 2021 | U01 | BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional) |
| RFA-HD-21-017 | July 30, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
July 31, 2020 | K12 | Child Health Research Career Development Award (CHRCDA) Program (K12 Clinical Trial Not Allowed) |
| PA-20-142 | Standard dates apply All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
May 26, 2023 | T32 | Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) |
| PAR-20-143 | May 15, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
May 16, 2020 | R61 | Firearm Injury and Mortality Prevention Research (R61 Clinical Trial Optional) |
| RFA-HD-21-005 | July 30, 2020 | July 31, 2020 | R01 | Genomic Predictors of Pregnancy Loss (R01 Clinical Trial Not Allowed) |
| PAR-20-137 | June 5, 2020 (new) and July 5, 2020 (renewal, resubmission, revision); October 5, 2020 (new) and November 5, 2020 (renewal, resubmission, revision); June 5, 2021 (new) and July 5, 2021 (renewal, resubmission, revision); October 5, 2021 (new) and November 5, 2021 (renewal, resubmission, revision); June 5, 2022 (new) and July 5, 2022 (renewal, resubmission, revision); October 5, 2022 (new) and November 5, 2022 (renewal, resubmission, revision) | November 6, 2022 | R01 | In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) |
| RFA-HD-21-014 | May 27, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
May 28, 2020 | T32 | Postdoctoral Training in Pediatric Clinical Pharmacology (T32 Clinical Trial Not Allowed) |
| RFA-HD-21-010 | July 30, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
July 31, 2020 | P2C | Population Dynamics Centers Research Infrastructure Program FY 2021 (P2C Clinical Trial Not Allowed) |
| PA-20-135 | See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
September 8, 2025 | 333 | Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) |
| PAR-20-126 | Standard dates apply The first standard application due date for this FOA is May 25, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
May 8, 2023 | P41 | NICHD Biomedical Informatic Resource Centers Grants (P41 Clinical Trial Not Allowed) |
| PAR-20-125 | June 24, 2020; June 24, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
July 24, 2021 | S06 | Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional) |
| PAR-20-122 | ?August 11, 2020, February 9, 2021, August 10, 2021, February 9, 2022 August 9, 2022, February 9, 2023 | May 8, 2023 | UG3/UH3 | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
| PAR-20-111 | August 11, 2020, February 9, 2021,August 10, 2021,February 9, 2022,August 9, 2022, February 9, 2023 by 5:00 PM local time of applicant organization. | May 8, 2023 | U44 | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) |
| RFA-AG-21-008 | May 18, 2020. No late applications will be accepted for this Funding Opportunity Announcement. | May 19, 2020 | U01 | National Longitudinal Study of Adolescent to Adult Health (Add Health) Wave 6 (U01 Clinical Trial Not Allowed) |
| RFA-MH-20-128 | September 3, 2020 and September 2, 2021 No late applications will be accepted for this Funding Opportunity Announcement. |
September 3, 2021 | R01 | BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed) |
| RFA-HD-21-011 | January 6, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
January 7, 2021 | P50 | Contraceptive Development Research Centers (CDRC) Program (P50 Clinical Trial Optional) |
| PAR-20-106 | Only accepting applications for the AIDS Application Due Date(s) listed below. | July 29, 2022 | P30 | Centers for AIDS Research (P30 Clinical Trial Not Allowed) |
| PAR-20-107 | Only accepting applications for the AIDS Application Due Date(s) listed below. | July 29, 2022 | P30 | Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) |
BACK TO TOP